Yi-Shan Liu | Dermatology | Best Researcher Award

Published on by World Top Scientists

Assoc. Prof. Dr. Yi-Shan Liu | Dermatology | Best Researcher Award

Chairman | I-Shou University | Taiwan

Assoc. Prof. Dr. Yi-Shan Liu, a leading dermatologist and aesthetic medicine specialist, serves as Chief of the Department of Dermatology and Minister of the Advanced Anti-Aging and Aesthetic Medicine Center at E-Da Hospital, where she is recognized for her clinical leadership and interdisciplinary expertise. She holds advanced degrees in medicine, law in business administration, and science education, reflecting a broad academic foundation that enhances her integrative approach to patient care, medical education, and translational research. Her professional experience spans progressive roles across major medical centers, where she has led dermatology services, contributed to aesthetic medicine initiatives, and guided multidisciplinary teams in delivering high-standard clinical practices. Her research focuses on dermatology, aesthetics, anti-aging science, and applied corneotherapy, with contributions that extend to scholarly publications, collaborative investigations, and international academic engagement. She has earned appointments as an associate professor across multiple academic programs and is an active member of numerous professional societies in dermatology and related fields, reflecting her recognized standing in the global medical community. Her professional certifications in medicine, dermatology, and hyperbaric and undersea medicine further attest to her clinical competence and commitment to continuous advancement. Dr. Liu’s combination of scholarly accomplishment, leadership experience, research productivity, and professional recognition positions her as an exemplary candidate for distinguished award nomination.

Profiles: ORCID

Featured Publications

1. Li, T. S., Wu, M. S., Sun, C. K., & Liu, Y. S. (2025). A novel banana method for surgical treatment of distal phalangeal glomus tumor. Asian Journal of Surgery, 48(11), 7228–7229.

2. Liu, Y. S., Lai, M. C., Hong, T. Y., & Liu, I. M. (2025). γ-Oryzanol: A nutrient-rich ingredient for promoting wound healing. Heliyon, 11(4), e42551.

3. Liu, Y.-S., Lai, M.-C., Tzeng, Y.-C., & Liu, I.-M. (2025). Polyphenolic hispolon derived from medicinal mushrooms of the Inonotus and Phellinus genera promotes wound healing in hyperglycemia-induced impairments. Nutrients, 17(2), 266.

4. Liu, Y.-S., Lai, M.-C., Hong, T.-Y., & Liu, I.-M. (2024). Exploring the wound healing potential of hispidin. Nutrients, 16(18), 3161.

5. Siregar, P., Liu, Y.-S., Casuga, F. P., Huang, C.-Y., Chen, K. H.-C., Huang, J.-C., Hung, C.-H., Lin, Y.-K., Hsiao, C.-D., & Lin, H.-Y. (2024). Optimization of laser-based method to conduct skin ablation in zebrafish and development of deep learning-based method for skin wound-size measurement. Inventions, 9(2), 25. (Co-first author)

Dr. Yi-Shan Liu’s work advances scientific understanding and clinical practice in dermatology, aesthetic medicine, and wound healing through integrative research and evidence-based innovation. Her contributions support improved patient outcomes, foster translational solutions for regenerative and anti-aging therapies, and strengthen global collaboration in emerging biomedical technologies.

Feyera Gemeda | Infectious Diseases | Outstanding Scientist Award

Published on by World Top Scientists

Assoc. Prof. Dr. Feyera Gemeda | Infectious Diseases | Outstanding Scientist Award

Associate Professor | Dima Jimma university | Ethiopia

Assoc. Prof. Dr. Feyera Gemeda Dima is a distinguished researcher and academic with extensive experience in Infectious Diseases, Medical Mycology, and Medicine. He has demonstrated excellence in teaching, research, and mentorship at both national and international levels, fostering the development of students and early-career researchers. His work emphasizes innovation in scientific research, editorial contributions, and leadership in grant assessment and curriculum development. He has contributed significantly to global collaborations and serves as a Chief Scientist and Global Assessor, reflecting his commitment to advancing scientific knowledge. His research focuses on improving understanding and management of infectious diseases, with the potential to influence public health strategies. Prof. Gemeda’s dedication to integrating innovative approaches and interdisciplinary perspectives underscores his capacity for impactful contributions in the field.

Profile:  Google Scholar

Featured Publications

1. T. Gizaw and F. G. Dima, “Assessment of problems and constraints associated with artificial insemination service in the two selected districts of Arsi zone,” Journal of Harmonized Research in Medical and Health Sciences, vol. 3, no. 1, pp. 14–37, 2016.

2. A. Edao, F. G. Dima, and F. B. Deressa, “Prevalence of bovine cysticercosis and status of human taeniasis in and around Asella town, Tiyoworeda, south east Ethiopia,” Glob J Med Res, vol. 16, pp. 18–26, 2016.

3. F. Gemeda, “Prevalence of bovine Trypanosomosis in and around Nekemte areas, east Wollega zone, Ethiopia,” Open Access Library Journal, vol. 2, no. 05, p. 1, 2015.

4. D. T. Legesse and F. Gemeda, “Comparison of two parasitological tests and post mortem examination to detect prevalence of bovine fasciolosis at Ambo Town Municipal Abattoir, West Shewa Zone, Ethiopia,” Open Access Library Journal, vol. 2, no. 8, pp. 1–5, 2015.

5. F. G. Dima and T. Fikedu, “Review on infectious bovine keratoconjunctivitis,” J Bacteriol Infect Dis, vol. 4, no. 4, pp. 1–6, 2021.

Dr. Gemeda’s work advances the understanding and control of infectious diseases, providing evidence-driven insights that strengthen public health systems and guide global disease management strategies.

Javad Amini Mahabadi | Medicine and Dentistry | Editorial Board Member

Published on by World Top Scientists

Dr. Javad Amini Mahabadi | Medicine and Dentistry | Editorial Board Member

Javad Amini Mahabadi  | Kashan University of Medical Sciences | Iran

Dr. Javad Amini Mahabadi, a reproductive biologist and faculty member at Kashan University of Medical Sciences, is recognized for his expertise in reproductive biology, IVF, and stem-cell–based approaches to fertility science. He holds advanced degrees culminating in a Ph.D. in Reproductive Biology, with specialized training in assisted reproductive technologies and cellular therapeutics. His professional experience includes leading laboratory initiatives in gamete and embryo research, contributing to multidisciplinary reproductive health projects, mentoring emerging scientists, and supporting institutional development through academic and committee service. Dr. Amini Mahabadi’s research focuses on reproductive physiology, embryo development, and innovative stem-cell applications, reflected in a substantial body of peer-reviewed publications and a strong citation record demonstrating sustained scientific impact. His contributions extend to methodological advancements and collaborative work aimed at improving clinical and translational outcomes in reproductive medicine. He has received institutional and professional recognitions for research excellence, serves in editorial and peer-review roles for respected journals, and maintains active membership in scientific societies that promote reproductive health and biomedical innovation.

Profiles: Google Scholar

Featured Publications

1. Mohammadi, F., Nikzad, H., Taherian, A., Amini Mahabadi, J., & Salehi, M. (2013). Effects of herbal medicine on male infertility. Anatomical Sciences Journal, 10(4), 3–16.

2. Aghaei, S., Nikzad, H., Taghizadeh, M., Tameh, A. A., Taherian, A., & Moravveji, A. (2014). Protective effect of pumpkin seed extract on sperm characteristics, biochemical parameters and epididymal histology in adult male rats treated with cyclophosphamide. Andrologia, 46(8), 927–935.

3. Abazari, M. F., Soleimanifar, F., Aleagha, M. N., Torabinejad, S., Nasiri, N., … (2018). PCL/PVA nanofibrous scaffold improve insulin-producing cells generation from human induced pluripotent stem cells. Gene, 671, 50–57.

4. Abazari, M. F., Soleimanifar, F., Amini Faskhodi, M., Mansour, R. N., … (2020). Improved osteogenic differentiation of human induced pluripotent stem cells cultured on polyvinylidene fluoride/collagen/platelet-rich plasma composite nanofibers. Journal of Cellular Physiology, 235(2), 1155–1164.

5. Tahmasebi, A. T., Enderami, S. E., Saburi, E., Islami, M., … (2019). MicroRNA incorporated electrospun nanofibers improve osteogenic differentiation of human induced pluripotent stem cells. Journal of Biomedical Materials Research, 108(2), 377–386.

Dr. Javad Amini Mahabadi’s work advances reproductive biology and stem-cell–based innovation, contributing to improved fertility outcomes and translational biomedical solutions. His research supports scientific progress, strengthens clinical practices, and fosters technologies that enhance public health and future therapeutic development.

Aneta Guzek | Bloodstream Infections | Best Researcher Award

Published on by World Top Scientists

Dr. Aneta Guzek | Bloodstream Infections | Best Researcher Award

Head of Microbial Laboratory | National Research Institute | Poland

Dr. Aneta Guzek is the Head of the Microbiology Laboratory at the Military Institute of Medicine – National Research Institute in Warsaw, Poland, specializing in medical microbiology and laboratory diagnostics. She holds a PhD in medicine with a specialization in medical microbiology from the Military Institute of Medicine, complemented by postgraduate qualifications in medical microbiology from the Medical University of Lublin and innovation management in the health care sector from Kozminski University. Additionally, she earned an MSc in biology with a focus on microbiology from the University of Warsaw and is a certified laboratory diagnostician. Dr. Guzek leads a multidisciplinary team overseeing comprehensive microbiological diagnostics, implementation of advanced diagnostic methods, and the development of institutional policies on infection control and antibiotic stewardship. Her research contributions include studies on antimicrobial resistance, hospital infection control, and the advancement of microbiological procedures, with numerous publications and citations in recognized scientific sources. She collaborates with national and reference laboratories, contributing to public health and medical innovation. Her exemplary service has been recognized with prestigious honors, including the first place in the Hippocrates Medical Poll for Laboratory Diagnostician of the Year and the Badge of Honour from the Military Medical Institute for her efforts during the COVID-19 pandemic. Dr. Guzek also holds certification in Good Clinical Practice (ICH E6 R2), underscoring her commitment to excellence in research and clinical integrity.

Profiles: Scopus | ORCID

Featured Publications

1. Guzek, A., et al. (2025). Microbiological comparison of maxillary sinus rinses in non-odontogenic and odontogenic sinusitis of primarily endodontic origin. Journal of Clinical Medicine.

2. Guzek, A., et al. (2024). Outcomes of 23 patients diagnosed with New Delhi metallo-beta-lactamase (NDM)-producing Klebsiella pneumoniae infection treated with ceftazidime/avibactam and aztreonam at a single center in Poland. Journal of Clinical Medicine.

3. Guzek, A., et al. (2024). Dissemination of extensively drug-resistant NDM-producing Providencia stuartii in Europe linked to patients transferred from Ukraine, March 2022 to March 2023. Eurosurveillance.

Carolin C. Hack | Medicine and Dentistry | Best Scholar Award

Published on by World Top Scientists

Dr. Carolin C. Hack | Medicine and Dentistry | Best Scholar Award

Deputy clinical director at Erlangen University Hospital Women’s Clinic, Germany

Priv.-Doz. Dr. med. Carolin Christine Hack is an accomplished medical professional and the Deputy Director of the Women’s Clinic at the University Hospital Erlangen. With a specialization in gynecological oncology and integrative medicine, Dr. Hack combines her clinical expertise with a passion for patient-centered care. Her innovative approach to medicine, along with her extensive training and research, positions her as a leading figure in her field.

Profile

Scopus

Education 🎓

Dr. Hack completed her medical degree at Friedrich-Alexander University Erlangen-Nuremberg, where she also pursued her habilitation in “Integrative Medicine in the Treatment of Gynecological Oncology Patients.” Her academic journey included a comprehensive curriculum that laid the groundwork for her clinical and research interests, ultimately leading to a robust foundation in both conventional and integrative medicine.

Experience 💼

With over a decade of experience at the University Hospital Erlangen, Dr. Hack has advanced through various roles, from assistant physician to Deputy Director of the Women’s Clinic. She has managed quality assurance initiatives and specialized in integrative medicine, focusing on the intersection of traditional and complementary therapies in patient care. Her leadership in the clinic has fostered a collaborative environment that emphasizes innovative treatment methodologies.

Research Interests 🔍

Dr. Hack’s research primarily focuses on integrative medicine and complementary therapy methods, with a specific emphasis on mammographic density as a risk factor for breast cancer. Her work seeks to enhance patient outcomes through evidence-based practices that incorporate holistic approaches to treatment.

Awards 🏆

Dr. Hack’s contributions to gynecological oncology have been recognized with multiple awards, including:

  • 2015: Klaus-Dieter-Schulz-Versorgungsforschungspreis
  • 2016: First Science Award from the German Society for Senology
  • 2018: Award from the Foundation for Women and Child Health
  • 2022: Research Award for Complementary Medicine from NATUM e.V.

Publications 📚

Dr. Hack has an extensive publication record, including:

  • The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype
    • Authors: Ziegler, P., Hartkopf, A.D., Wallwiener, M., Schneeweiss, A., Goossens, C.
    • Journal: BMC Cancer
    • Year: 2024
    • Volume: 24(1), Article 1284
  • Tumor-Associated Neutrophils Are a Negative Prognostic Factor in Early Luminal Breast Cancers Lacking Immunosuppressive Macrophage Recruitment
    • Authors: Schmidt, E., Distel, L., Erber, R., Fietkau, R., Schnellhardt, S.
    • Journal: Cancers
    • Year: 2024
    • Volume: 16(18), Article 3160
  • Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole
    • Authors: Fasching, P.A., Hack, C.C., Nabieva, N., Fehm, T.N., Häberle, L.
    • Journal: European Journal of Cancer
    • Year: 2024
    • Volume: 209, Article 114239
  • Correlation of RANK and RANKL with mammographic density in primary breast cancer patients
    • Authors: Wunderle, M., Heindl, F., Behrens, A.S., Fasching, P.A., Emons, J.
    • Journal: Archives of Gynecology and Obstetrics
    • Year: 2024
    • Volume: 310(2), pp. 1223–1233
  • CDK4/6 Inhibition – Therapy Sequences and the Quest to Find the Best Biomarkers – An Overview of Current Programs
    • Authors: Schneeweiss, A., Brucker, S.Y., Huebner, H., Fehm, T.N., Fasching, P.A.
    • Journal: Geburtshilfe und Frauenheilkunde
    • Year: 2024
    • Volume: 84(5), pp. 443–458
  • Initial experience with a next-generation low-field MRI scanner: Potential for breast imaging?
    • Authors: Dietzel, M., Laun, F.B., Heiß, R., Uder, M., Ohlmeyer, S.
    • Journal: European Journal of Radiology
    • Year: 2024
    • Volume: 173, Article 111352
  • Unbiased high-dimensional flow cytometry identified NK and DC immune cell signature in Luminal A-type and triple negative breast cancer
    • Authors: Heger, L., Heidkamp, G.F., Amon, L., Beckmann, M.W., Dudziak, D.
    • Journal: OncoImmunology
    • Year: 2024
    • Volume: 13(1), Article 2296713
  • Predicting mammographic density with linear ultrasound transducers
    • Authors: Behrens, A., Fasching, P.A., Schwenke, E., Beckmann, M.W., Emons, J.
    • Journal: European Journal of Medical Research
    • Year: 2023
    • Volume: 28(1), Article 384
  • Evaluation of automated techniques for extraction of circulating cell-free DNA for implementation in standardized high-throughput workflows
    • Authors: Lehle, S., Emons, J., Hack, C.C., Ruebner, M., Huebner, H.
    • Journal: Scientific Reports
    • Year: 2023
    • Volume: 13(1), Article 373
  • Long-term Follow-up and Safety of Patients after an Upfront Therapy with Letrozole for Early Breast Cancer in Routine Clinical Care – The PreFace Study
    • Authors: Hack, C.C., Maass, N., Aktas, B., Hein, A., Fasching, P.A.
    • Journal: Geburtshilfe und Frauenheilkunde
    • Year: 2023
    • Volume: 84(2), pp. 185–195

Conclusion ✨

Priv.-Doz. Dr. med. Carolin Christine Hack is an exemplary candidate for the Best Researcher Award. Her innovative contributions to integrative medicine and gynecological oncology, coupled with her extensive publication record and commitment to patient care, position her as a leader in her field. By addressing areas for improvement, such as interdisciplinary collaboration and public engagement, Dr. Hack can further enhance her impact in research and continue to advance the frontiers of medical knowledge.